Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001396814-25-000109
Filing Date
2025-09-08
Accepted
2025-09-08 17:37:14
Documents
1
Period of Report
2025-09-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1757367430.html 4  
1 FORM 4 wk-form4_1757367430.xml 4 3306
  Complete submission text file 0001396814-25-000109.txt   5088
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SCPHARMACEUTICALS, INC. 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830
Business Address
Ceesay Abraham (Reporting) CIK: 0001722140 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 251301070